ArticleMolecular therapy. Nucleic acids2024

Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP kinase inhibition against BRAF-mutated melanoma.

Christian Grützner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.